geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model


, : Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model. Molecular Brain 7(): 65-65

Profound synapse loss is one of the major pathological hallmarks associated with Alzheimer's disease, which might underlie memory impairment. Our previous work demonstrates that magnesium ion is a critical factor in controlling synapse density/plasticity. Here, we tested whether elevation of brain magnesium, using a recently developed compound (magnesium-L-threonate, MgT), can ameliorate the AD-like pathologies and cognitive deficits in the APPswe/PS1dE9 mice, a transgenic mouse model of Alzheimer's disease. MgT treatment reduced Aβ-plaque, prevented synapse loss and memory decline in the transgenic mice. Strikingly, MgT treatment was effective even when the treatment was given to the mice at the end-stage of their Alzheimer's disease-like pathological progression. To explore how elevation of brain magnesium ameliorates the AD-like pathologies in the brain of transgenic mice, we studied molecules critical for APP metabolism and signaling pathways implicated in synaptic plasticity/density. In the transgenic mice, the NMDAR signaling pathway was downregulated, while the BACE1 expression were upregulated. MgT treatment prevented the impairment of these signaling pathways, stabilized BACE1 expression and reduced sAPPβ and β-CTF in the transgenic mice. At the molecular level, elevation of extracellular magnesium prevented the high Aβ-induced reductions in synaptic NMDARs by preventing calcineurin overactivation in hippocampal slices. Our results suggest that elevation of brain magnesium exerts substantial synaptoprotective effects in a mouse model of Alzheimer's disease, and hence it might have therapeutic potential for treating Alzheimer's disease.

US$19.90

PMID: 25213836

DOI: 10.1186/s13041-014-0065-y


Other references

Milledge, J.S., 2001: Opioids in chronic non-malignant pain. Opioids can cause addiction even in patients with pain. Bmj 323(7312): 571-572

Bigorgne, E.; Custer, T.W.; Dummer, P.M.; Erickson, R.A.; Karouna-Renier, N.; Schultz, S.; Custer, C.M.; Thogmartin, W.E.; Matson, C.W., 2016: Chromosomal damage and EROD induction in tree swallows (Tachycineta bicolor) along the Upper Mississippi River, Minnesota, USA. The health of tree swallows, Tachycineta bicolor, on the Upper Mississippi River (UMR) was assessed in 2010 and 2011 using biomarkers at six sites downriver of Minneapolis/St. Paul, MN metropolitan area, a tributary into the UMR, and a nearby lake...

Del Zoppo, G.J., 1993: Thrombolytic therapy of early stroke. Tomita, M [Editor], Mchedlishvili, G [Editor], Rosenblum, W I [Editor], Heiss, W -D [Editor], Fukuuchi, Y [Editor] International Congress Series; Microcirculatory stasis in the brain 527-538

Kryshova, N.A.; Shteingart, K.M., 1960: The state of the speech-directing analyzer in aphasia. Doklady Akad Nauk Sssr [Biol Sci Sect Transl] 130(1/6): 153-155

Nemcok Michal; Henk Andreas, 2001: Oil in foreland sourced by thrustbelt; insights from numerical stress modeling and balancing in the West Carpathians. The West Carpathian accretionary wedge advanced northeastwards over the European Platform. Its thrust sheets comprise sediments of the Early Cretaceous rifts that evolved on a passive margin of the European Platform, the Late Cretaceous-Paleocene...

Ghosh, J.; Burman, A.; Manna, A.Kumar.; Chatterjee, A., 2005: Role of proliferative markers in prostatic lesions. Prostatic lesions on routine H&E stain sometimes cause diagnostic dilemma specially in premalignant lesions like A.A.H. and P.I.N. Proliferative markers (AgNOR, P.C.N.A) are of great help in this grey zone. Total 50 cases studied and provision...

Tsutsui, K.; Ukena, K.; Takase, M.; Kohchi, C.; Lea, R.W., 1999: Neurosteroid biosynthesis in vertebrate brains. In mammals, neurosteroids are now known to be synthesized de novo in the brain as well as other areas of the nervous system through mechanisms at least partly independent of the peripheral steroidogenic glands. However, limited information is avai...

Rothbaum, B.O.; Hodges, L.; Alarcon, R.; Ready, D.; Shahar, F.; Graap, K.; Pair, J.; Hebert, P.; Gotz, D.; Wills, B.; Baltzell, D., 1999: Virtual reality exposure therapy for PTSD Vietnam Veterans: a case study. Virtual reality (VR) integrates real-time computer graphics, body tracking devices, visual displays, and other sensory input devices to immerse a participant in a computer-generated virtual environment that changes in a natural way with head and b...

Gerber, L.; Giovarelli, R., 2005: Land reform and land markets in Eastern Europe. This article reviews the status of agricultural land markets in 23 Eastern European countries, with particular emphasis on regional differences. Three major topics are surveyed as indicators of progress in the development of land markets: (i) the...

Silverstein, D.M.; Thornhill, B.A.; Trachtman, H.; Chevalier, R.L., 2001: Expression of connexins in congenital obstructive uropathy. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 716A-717A, September